The knockdown of SLC25A10 changes the growth properties to a less malignant phenotype and causes increased glutamine dependency and sensitivity to oxidative stress in human lung adenocarcinoma cells, suggesting SLC25A10 as a novel target for anticancer strategies (13). This evidence concerns the gene SLC25A10 and lung adenocarcinoma.